| Patents for C07D 491 - Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups , , or (29,726) |
|---|
| 01/09/2013 | EP2543667A1 2-aminopyridine analogs as glucokinase activators |
| 01/09/2013 | EP2543380A1 Neural stem cells proliferation promoting agent |
| 01/09/2013 | EP2542545A1 Inhibitors of hepatitis c virus ns5b polymerase |
| 01/09/2013 | CN102869667A Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 01/09/2013 | CN102869659A Bicarbazole containing compounds for OLEDs |
| 01/09/2013 | CN102869359A Imidazopyridine compounds, compositions and methods of use |
| 01/09/2013 | CN102863451A Preparation method and usage of triphenylamine molecule-containing chromene and naphthyridine fluorescent compound |
| 01/09/2013 | CN102863428A Spiro-compounds taken as hepatitis c virus (HCV) inhibitor |
| 01/08/2013 | US8349863 Crystalline polymorphic form of a camptothecin analogue |
| 01/08/2013 | US8349843 Carboxylic acid derivatives, their preparation and use |
| 01/08/2013 | CA2527420C Compounds, methods and pharmaceutical compositions for inhibiting parp |
| 01/08/2013 | CA2510337C Topoisomerase-targeting agents |
| 01/08/2013 | CA2478731C Carbamates as hiv protease inhibitors |
| 01/08/2013 | CA2478065C Macrocyclic compounds useful as pharmaceuticals |
| 01/03/2013 | WO2013002357A1 Hiv replication inhibitor |
| 01/03/2013 | WO2013000269A1 Camptothecin derivative, method for preparing same, pharmaceutical composition and use thereof |
| 01/03/2013 | WO2012062905A3 Chromene derivatives and their analoga as wnt pathway antagonists |
| 01/03/2013 | US20130005727 Quinazoline derivatives |
| 01/03/2013 | US20130005723 Triazine compounds as pi3 kinase and mtor inhibitors |
| 01/03/2013 | US20130005705 Novel inhibitor compounds of phosphodiesterase type 10a |
| 01/03/2013 | US20130005675 Quinolone compound and pharmaceutical composition |
| 01/03/2013 | CA2838875A1 Camptothecin derivative, method for preparing same, pharmaceutical composition and use thereof |
| 01/02/2013 | EP2540719A1 Cyclic amine compound and miticide |
| 01/02/2013 | EP2540715A1 Fused substituted aminopyrrolidine derivative |
| 01/02/2013 | EP2539322A1 Inhibitors of beta-secretase |
| 01/02/2013 | CN102858780A Substituted pyridazines having herbicidal action |
| 01/02/2013 | CN102850363A Irinotecan hydrochloride compound and pharmaceutical composition thereof |
| 01/02/2013 | CN102850362A Preparation method of Pancratistatin |
| 01/02/2013 | CN102850361A Method for extracting 5-hydroxy nor naringin alkali from oranges |
| 01/02/2013 | CN102850336A Derivatives of 4-piperazin-1-yl-4-benz0 [b] thiophene suitable for the treatment of cns disorders |
| 01/02/2013 | CN102146083B Method for separating and extracting cepharanthine |
| 01/02/2013 | CN101878218B Icotinib hydrochloride, synthesis, crystallographic form, medical combination, and uses thereof |
| 01/02/2013 | CN101687879B 5-furopyridinone substituted indazoles |
| 01/01/2013 | US8343982 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 01/01/2013 | US8343729 Luciferin luminescent substrate of marine ostracod crustacean and method for production thereof |
| 12/27/2012 | WO2012176818A1 Organic electroluminescent element |
| 12/27/2012 | WO2012175991A1 Fused pentacyclic anti - proliferative compounds |
| 12/27/2012 | WO2012175520A1 Hydroxy substituted isoquinolinone derivatives |
| 12/27/2012 | WO2012175002A1 Derivate, preparation method and use of 10-methoxycamptothecine |
| 12/27/2012 | WO2012174699A1 A series of ecteinascidins analogs with anti-tumor effect |
| 12/27/2012 | US20120330019 Hepatitis C Virus Inhibitors |
| 12/27/2012 | US20120329773 Bicyclic ring system substituted amide functionalised phenols as medicaments |
| 12/27/2012 | US20120329772 Amino-tetrazoles analogues and methods of use |
| 12/26/2012 | EP2536733A1 Tricyclic pyridine derivatives, medicaments containing such compounds, their use and process for their preparation |
| 12/26/2012 | EP2536711A1 5-ht receptor modulators |
| 12/26/2012 | EP2536706A1 Arylmethoxy isoindoline derivatives and compositions comprising and methods of using the same |
| 12/26/2012 | CN102844304A Nitrogen-containing heterocyclic compound and agricultural/horticultural germicide |
| 12/26/2012 | CN102838609A Azabicyclo [3.3.0] octane derivative, as well as preparation method and application thereof |
| 12/26/2012 | CN102838608A Preparation method of hernanymphine |
| 12/26/2012 | CN102838602A 培美曲塞氧化物及其制备方法 Pemetrexed oxide and its preparation method |
| 12/26/2012 | CN102838578A Salt and coloring curing combination |
| 12/25/2012 | US8338452 Raf inhibitor compounds and methods of use thereof |
| 12/25/2012 | US8338448 Chemokine receptor modulators |
| 12/25/2012 | US8338442 Remedies for psychoneurosis |
| 12/25/2012 | US8338431 Phosphodiesterase inhibitors |
| 12/25/2012 | US8338406 Benzodiazepine compound and pharmaceutical composition |
| 12/25/2012 | US8338140 Polymeric carriers of therapeutic agents and recognition moieties for antibody-based targeting of disease sites |
| 12/20/2012 | WO2012171863A1 New selective ccr2 antagonists |
| 12/20/2012 | WO2012171860A1 Tricyclic antibiotics |
| 12/20/2012 | WO2012171506A1 Compounds, their pharmaceutical compositions and their uses as idh1 mutants inhibitors for treating cancers |
| 12/20/2012 | US20120323000 Z-selective ring-closing metathesis reactions |
| 12/20/2012 | US20120322791 PYRAZOLO[1,5-a]PYRIMIDINE COMPOUNDS AS mTOR INHIBITORS |
| 12/20/2012 | US20120322784 Compounds, pharmaceutical compositions and uses thereof |
| 12/20/2012 | US20120318348 Organic photovoltaic-battery hybrid device |
| 12/20/2012 | CA2839616A1 Therapeutically active compositions and their methods of use |
| 12/20/2012 | CA2838036A1 Tricyclic antibiotics |
| 12/20/2012 | CA2837268A1 Compositions and methods for modulating a kinase |
| 12/19/2012 | EP2535329A2 Spiro-piperidine derivatives |
| 12/19/2012 | EP2534156A1 7-aminofuropyridine derivatives |
| 12/19/2012 | CN102834513A Antiviral therapeutic agents |
| 12/19/2012 | CN102834381A Derivatives of pyridoxine for inhibiting HIV integrase |
| 12/19/2012 | CN102827893A Ester exchange method synthesizing process of aryl acetic acid (propionic acid) L-ascorbic acid ester |
| 12/19/2012 | CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof |
| 12/19/2012 | CN102827178A Method for extracting akuammine from red mahogany oleander wood |
| 12/19/2012 | CN102827177A Method for preparing henningsoline |
| 12/19/2012 | CN102827176A Preparation method and application of fluorescein molecular probe material |
| 12/19/2012 | CN102827175A N-(2,4-dinitrophenyl)-rhodamine B hydrazide and preparation method and application thereof |
| 12/19/2012 | CN102827174A Preparation method for aldose reductase inhibitor fidarestat |
| 12/19/2012 | CN102827173A Method for extracting and purifying cycloclausenamide from Clausena lansium |
| 12/19/2012 | CN102827172A Pyrano[2,3-c]pyrazole compounds, and preparation and application thereof |
| 12/19/2012 | CN102827171A Method for preparing wine bread Lening |
| 12/19/2012 | CN102827170A Active treatment compositions and use method thereof |
| 12/19/2012 | CN102826946A Green synthesis process of aryl methyl low-carbonate |
| 12/18/2012 | US8334300 C2-phenyl-substituted cyclic ketonols |
| 12/18/2012 | US8334236 Ring-fused 2-pyridone derivatives and herbicides |
| 12/18/2012 | CA2661354C New small molecule inhibitors of mdm2 and the uses thereof |
| 12/18/2012 | CA2631732C Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase |
| 12/18/2012 | CA2577758C Gyrase inhibitors and uses thereof |
| 12/18/2012 | CA2517517C P38 inhibitors and methods of use thereof |
| 12/13/2012 | WO2012171002A1 Synthesis and characterization of second generation benzofuranone ring substituted noscapine analogs |
| 12/13/2012 | WO2012169821A1 Novel compounds for organic electronic material and organic electroluminescent device using the same |
| 12/13/2012 | WO2012169575A1 Method for manufacturing optically active carboxylic acid ester |
| 12/13/2012 | WO2012168350A1 Pyridin- 2 -amides useful as cb2 agonists |
| 12/13/2012 | WO2012143080A3 Materials for organic electroluminescent devices |
| 12/13/2012 | US20120316342 Therapeutic agent for hepatitis c |
| 12/13/2012 | US20120316341 Fluorination of organic compounds |
| 12/13/2012 | US20120316195 Aryl-pyridine derivatives as aldosterone synthase inhibitors |
| 12/13/2012 | US20120316162 Piperidine and piperazine derivatives |
| 12/13/2012 | US20120316154 Fused tricyclic compounds for the treatment of inflammatory disorders |
| 12/13/2012 | US20120316148 Compositions and Methods for Modulating a Kinase |